Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-06-15
4:30 pm
Purchase
13DElevation Oncology, Inc.
ELEV
venBio Global Strategic Fund III L.P.2,537,771
6.1%
671,432increase
(+35.98%)
View
2023-06-09
4:15 pm
Purchase
13GElevation Oncology, Inc.
ELEV
ExodusPoint Capital Management LP1,414,824
5.8%
1,414,824increase
(New Position)
View
2023-06-08
4:30 pm
Purchase
13GElevation Oncology, Inc.
ELEV
INTEGRATED CORE STRATEGIES (US) LLC1,397,382
5.7%
1,397,382increase
(New Position)
View
2023-05-24
5:15 pm
Purchase
13GElevation Oncology, Inc.
ELEV
Point72 Asset Management L.P.2,121,170
8.7%
2,121,170increase
(New Position)
View
2023-02-24
4:00 pm
Purchase
13GElevation Oncology, Inc.
ELEV
TANG CAPITAL PARTNERS LP1,355,826
5.8%
1,355,826increase
(New Position)
View
2023-02-14
3:15 pm
Sale
13GElevation Oncology, Inc.
ELEV
Cormorant Asset Management LP1,952,032
8.38%
-31,136decrease
(-1.57%)
View
2023-02-13
6:05 pm
Purchase
13GElevation Oncology, Inc.
ELEV
BIOTECHNOLOGY VALUE FUND L P2,312,200
9.9%
700,502increase
(+43.46%)
View
2023-02-08
5:00 pm
Purchase
13GElevation Oncology, Inc.
ELEV
Aisling Capital IV LP2,876,561
12.34%
10,413increase
(+0.36%)
View
2022-09-30
5:24 pm
Purchase
13GElevation Oncology, Inc.
ELEV
K2 HealthVentures Equity Trust LLC1,566,464
6.3%
1,566,464increase
(New Position)
View
2022-09-26
4:21 pm
Unchanged
13DElevation Oncology, Inc.
ELEV
venBio Global Strategic Fund III L.P.1,866,339
8%
0
(Unchanged)
View
2022-07-11
10:28 am
Sale
13GElevation Oncology, Inc.
ELEV
Driehaus Capital Management LLC1,044,244
4.49%
-458,524decrease
(-30.51%)
View
2022-06-10
09:02 am
Sale
13GElevation Oncology, Inc.
ELEV
Driehaus Capital Management LLC1,502,768
6.46%
-479,695decrease
(-24.20%)
View
2022-05-27
5:26 pm
Sale
13DElevation Oncology, Inc.
ELEV
venBio Global Strategic Fund III L.P.1,866,339
8.03%
-741,828decrease
(-28.44%)
View
2022-02-14
4:21 pm
Sale
13GElevation Oncology, Inc.
ELEV
Boxer Capital LLC872,780
3.8%
-468,750decrease
(-34.94%)
View
2022-02-14
1:46 pm
Purchase
13GElevation Oncology, Inc.
ELEV
BIOTECHNOLOGY VALUE FUND L P1,611,698
6.9%
1,611,698increase
(New Position)
View
2022-02-14
12:16 pm
Purchase
13GElevation Oncology, Inc.
ELEV
Aisling Capital IV LP2,866,148
12.33%
2,866,148increase
(New Position)
View
2022-02-14
09:19 am
Purchase
13GElevation Oncology, Inc.
ELEV
Driehaus Capital Management LLC1,982,463
8.54%
1,982,463increase
(New Position)
View
2022-02-08
4:15 pm
Purchase
13GElevation Oncology, Inc.
ELEV
Qiming U.S. Healthcare GP II LLC2,370,142
10.2%
2,370,142increase
(New Position)
View
2022-01-18
4:00 pm
Purchase
13GElevation Oncology, Inc.
ELEV
Vertex Global HC Fund II Pte. Ltd.2,307,642
9.94%
2,307,642increase
(New Position)
View
2021-07-09
4:31 pm
Purchase
13GElevation Oncology, Inc.
ELEV
Boxer Capital LLC1,341,530
5.9%
1,341,530increase
(New Position)
View
Goto 0, 1, Next